Breaking News
Upgrade 0
🚀 5 new AI-picked strategies for US stocks beating the market in healthcare, energy & more
Learn more
Close

Aurobindo Pharma Ltd. (ARBN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,101.00 -5.30    -0.48%
10:59:59 - Closed. Currency in INR
Type:  Equity
Market:  India
ISIN:  INE406A01037 
S/N:  AUROPHARMA
  • Volume: 938,051
  • Bid/Ask: 1,101.00 / 1,101.00
  • Day's Range: 1,092.80 - 1,113.50
Aurobindo Pharma 1,101.00 -5.30 -0.48%

Aurobindo Pharma Ltd. Company Profile

 
Get an in-depth profile of Aurobindo Pharma Ltd., including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

27707

Equity Type

ORD

Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Contact Information

Address Galaxy, Plot No. 1 22nd-24th Floor, Survey No.83/1
Hyderabad Knowledge City, Raidurg Panmaktha Rangareddy District Hyderabad,500032
India
Phone 91 40 6672 5000
Fax 91 40 6707 4044

Top Executives

Name Age Since Title
Mettu Madan Mohan Reddy 65 2006 Whole-Time Director
Penaka Sarath Chandra Reddy 40 2007 Non-Executive Director
Santanu Mukherjee 69 2023 Independent Director
Venkat Nageswar Chalasani 64 2023 Independent Director of Apitoria Pharma Private Limited
Mangalam Ramasubramanian Kumar 64 2024 Independent Non-Executive Chairman
Makkapati Satakarni 44 2016 President of Biologics, CEO of Biologics, Vaccines and Peptid & Director
Penaka Venkata Ramprasad Reddy 67 1986 Non-Executive Director
Kambam Nithyananda Reddy 67 1986 Vice Chairman & MD
Deepali Pant Rajeev Joshi 68 2024 Independent Director
Girish Paman Vanvari 52 2020 Non-Executive Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARBN Comments

Write your thoughts about Aurobindo Pharma Ltd.
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email